Sign up for Table of Contents Alerts.
Cell Cycle is published 24 times a year.
Email this page
Print this page
Perspectives
p38 MAPK in Development and Cancer
Cynthia Bradham and David R. McClay
volume 5 | issue 8
15 april 2006Pages: 824 - 828
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDF If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
p38 is a MAPK that has been shown to induce a wide variety of biological effects in cell culture, in response to a wide range of stimuli. These effects are dependent not only on the stimuli, but also on the cellular context, resulting in a bewildering array of possibilites1. For example, p38 was shown to induce apoptosis in some cells, but prevent apoptosis in others2. Similarly opposed effects had been observed with respect to cell cycle regulation2. The role of p38 in inflammatory disease has been appreciated from the beginning, since it was initially identified as an cytokine inducer3. More recently, p38 function has been evaluated in vivo, and through these studies p38 has emerged as an important regulator of both embryonic development and cancer progression. This review will focus on these in vivo studies in an effort to provide perspective on p38 biologically and as a pharmacological target.
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDF If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.